Advertisement
Early High-Titer Plasma Reduces Progression of COVID-19

IgG Level in Convalescent Plasma Affects COVID-19 Death Risk

0

Risk for death reduced with higher versus lower levels of anti-SARS-CoV-2 IgG, but only in patients not receiving mechanical ventilation

Los bebés amamantados quizá sean adolescentes mejor ajustados

COVID-19 Vaccine Likely Safe for Lactating Women

0

However, Academy of Breastfeeding Medicine calls for lactating women to be included in trials

Cinco consejos para dejar de fumar en 2021

USPSTF Affirms Evidence-Based Methods for Smoking Cessation

0

Behavioral and pharmacotherapy interventions, alone or in combination, recommended; evidence insufficient for e-cigarettes

HealthDay Reports: Most Americans

California First State With Over 3 Million COVID-19 Cases

0

Biden administration has said it will not be lifting restrictions on international travel

La vacuna de Pfizer contra la COVID parece promisoria

One-Third of U.S. Adults Likely to Refuse a COVID-19 Vaccine

0

Blacks, women, and conservatives more hesitant in the United States

Stopping RAS Inhibitors May Worsen Outcomes in CKD

0

Stopping therapy tied to lower risk for dialysis, but higher risk for cardiovascular events and death

HealthDay Reports: COVID-19 Roundup for the Week of June 29-July 3

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
更年期症状が多いほど仕事のパフォーマンスが低下?

Primary Care-Recorded Mental Illness Decreased During COVID-19

0

Reductions seen in incidence of primary care-recorded depression, anxiety disorders, first antidepressant prescribing in United Kingdom

Triplet Therapy Slows Refractory Multiple Myeloma

Bupropion-Naltrexone Bests Placebo in Methamphetamine Use Disorder

0

Response was low but higher with naltrexone-bupropion than placebo during 12-week, two-stage trial

One-Dose Covid-19 Vaccine From Johnson & Johnson Looks Promising

U.S. COVID-19 Vaccine Rollout Nears 1 Million Doses Per Day

0

News comes as Ohio State University researchers discover new variant of COVID-19 virus